BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30001465)

  • 1. Tube Feeding with a Diabetes-Specific Enteral Formula Improves Glycemic Control in Severe Acute Ischemic Stroke Patients.
    Shao Y; Heng W; Li S; Xu Y; Hu G
    JPEN J Parenter Enteral Nutr; 2018 Jul; 42(5):926-932. PubMed ID: 30001465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study.
    Mesejo A; Montejo-González JC; Vaquerizo-Alonso C; Lobo-Tamer G; Zabarte-Martinez M; Herrero-Meseguer JI; Acosta-Escribano J; Blesa-Malpica A; Martinez-Lozano F
    Crit Care; 2015 Nov; 19():390. PubMed ID: 26549276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Diabetes-Specific Enteral Nutrition Formula on Cardiometabolic Parameters in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
    Ojo O; Weldon SM; Thompson T; Crockett R; Wang XH
    Nutrients; 2019 Aug; 11(8):. PubMed ID: 31443185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a diabetes-specific formula in non-diabetic inpatients with stroke: a randomized controlled trial.
    López-Gómez JJ; Delgado García E; Primo-Martín D; Simón de la Fuente M; Gómez-Hoyos E; Jiménez-Sahagún R; Torres-Torres B; Ortolá-Buigues A; Gómez-Vicente B; Arenillas-Lara JF; De Luis Román DA
    Nutr Diabetes; 2024 May; 14(1):34. PubMed ID: 38816400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: a double-blind randomized trial.
    de Aguilar-Nascimento JE; Prado Silveira BR; Dock-Nascimento DB
    Nutrition; 2011 Apr; 27(4):440-4. PubMed ID: 21167685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes.
    Alish CJ; Garvey WT; Maki KC; Sacks GS; Hustead DS; Hegazi RA; Mustad VA
    Diabetes Technol Ther; 2010 Jun; 12(6):419-25. PubMed ID: 20470226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of a high-protein disease-specific enteral formula with a high-protein enteral formula in hyperglycemic critically ill patients.
    Mesejo A; Acosta JA; Ortega C; Vila J; Fernández M; Ferreres J; Sanchis JC; López F
    Clin Nutr; 2003 Jun; 22(3):295-305. PubMed ID: 12765670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas.
    Vanschoonbeek K; Lansink M; van Laere KM; Senden JM; Verdijk LB; van Loon LJ
    Diabetes Educ; 2009; 35(4):631-40. PubMed ID: 19448045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycemic Effects of a Low-Carbohydrate Enteral Formula Compared With an Enteral Formula of Standard Composition in Critically Ill Patients: An Open-Label Randomized Controlled Clinical Trial.
    van Steen SC; Rijkenberg S; Sechterberger MK; DeVries JH; van der Voort PHJ
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1035-1045. PubMed ID: 30133840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved Glucose Profile in Patients With Type 2 Diabetes With a New, High-Protein, Diabetes-Specific Tube Feed During 4 Hours of Continuous Feeding.
    Lansink M; Hofman Z; Genovese S; Rouws CHFC; Ceriello A
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):968-975. PubMed ID: 26826263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial.
    Pohl M; Mayr P; Mertl-Roetzer M; Lauster F; Haslbeck M; Hipper B; Steube D; Tietjen M; Eriksen J; Rahlfs VW
    JPEN J Parenter Enteral Nutr; 2009; 33(1):37-49. PubMed ID: 19011146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of standard enteral formula versus enteric formula with prebiotic content in nutrition therapy: A randomized controlled study among neuro-critical care patients.
    Tuncay P; Arpaci F; Doganay M; Erdem D; Sahna A; Ergun H; Atabey D
    Clin Nutr ESPEN; 2018 Jun; 25():26-36. PubMed ID: 29779815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A real-life study of the medium to long-term effectiveness of a hypercaloric, hyperproteic enteral nutrition formula specifically for patients with diabetes on biochemical parameters of metabolic control and nutritional status.
    Ballesteros Pomar MD; Lardiés Sánchez B; Argente Pla M; Ramos Carrasco A; Suárez Gutiérrez L; Yoldi Arrieta A; Sorribes Carreras P; Gutiérrez Medina S; Molina Soria JB; Berrio Miranda M; Leyva Martínez MS; Torregrosa Suau O; Oliván Usieto MT; Villazón González F; Abilés Osinaga J; Martín Echevarría E; García-Malpartida K
    Endocrinol Diabetes Nutr (Engl Ed); 2022 May; 69(5):331-337. PubMed ID: 35523676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safer glycemic control using isomaltulose-based enteral formula: a pilot randomized crossover trial.
    Egi M; Toda Y; Katayama H; Yokoyama M; Morita K; Arai H; Yamatsuji T; Bailey M; Naomoto Y
    J Crit Care; 2010 Mar; 25(1):90-6. PubMed ID: 19781899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very high-protein and low-carbohydrate enteral nutrition formula and plasma glucose control in adults with type 2 diabetes mellitus: a randomized crossover trial.
    Huhmann MB; Yamamoto S; Neutel JM; Cohen SS; Ochoa Gautier JB
    Nutr Diabetes; 2018 Aug; 8(1):45. PubMed ID: 30158516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a Low-carbohydrate Enteral Nutrition Formula with Effective Inhibition of Hypoglycemia and Post-infusion Hyperglycemia in Non-diabetic Patients Fed via a Jejunostomy Tube.
    Nishiwaki S; Fujimoto H; Kurobe T; Baba A; Iwashita M; Hatakeyama H; Hayashi T; Maeda T
    Intern Med; 2020 Aug; 59(15):1803-1809. PubMed ID: 32461526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of Hyperglycemia and Hypoglycemia in Patients with Acute Ischemic Stroke Based on Continuous Glucose Monitoring.
    Nukui S; Akiyama H; Soga K; Takao N; Tsuchihashi Y; Iijima N; Hasegawa Y
    J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104346. PubMed ID: 31548085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress hyperglycemia and acute ischemic stroke in-hospital outcome.
    Tziomalos K; Dimitriou P; Bouziana SD; Spanou M; Kostaki S; Angelopoulou SM; Papadopoulou M; Giampatzis V; Savopoulos C; Hatzitolios AI
    Metabolism; 2017 Feb; 67():99-105. PubMed ID: 28081783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, controlled, a single-blind trial of nutritional supplementation after acute stroke.
    Gariballa SE; Parker SG; Taub N; Castleden CM
    JPEN J Parenter Enteral Nutr; 1998; 22(5):315-9. PubMed ID: 9739036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-Care Costs, Glycemic Control and Nutritional Status in Malnourished Older Diabetics Treated with a Hypercaloric Diabetes-Specific Enteral Nutritional Formula.
    Sanz-Paris A; Boj-Carceller D; Lardies-Sanchez B; Perez-Fernandez L; Cruz-Jentoft AJ
    Nutrients; 2016 Mar; 8(3):153. PubMed ID: 27005661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.